BlueRock Therapeutics Appoints Seth Ettenberg, Ph.D. Chief Scientific Officer
March 03, 2020 08:32 ET
|
BlueRock Therapeutics, LLC.
CAMBRIDGE, Mass., March 03, 2020 (GLOBE NEWSWIRE) -- BlueRock Therapeutics, LP today announced the addition of Seth Ettenberg, Ph.D. to the company’s senior leadership team. In his role as Chief...